 Gareth Morgan
Concepts (458)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Catheterization | 58 | 2023 | 534 | 10.270 |
Why?
| | Stents | 29 | 2023 | 475 | 7.600 |
Why?
| | Pulmonary Valve | 16 | 2023 | 89 | 7.230 |
Why?
| | Heart Defects, Congenital | 34 | 2023 | 671 | 5.850 |
Why?
| | Heart Valve Prosthesis Implantation | 14 | 2023 | 174 | 5.560 |
Why?
| | Heart Valve Prosthesis | 12 | 2023 | 121 | 5.400 |
Why?
| | Septal Occluder Device | 14 | 2023 | 46 | 5.040 |
Why?
| | Pulmonary Valve Insufficiency | 9 | 2022 | 41 | 4.470 |
Why?
| | Aortic Coarctation | 10 | 2022 | 69 | 4.040 |
Why?
| | Prosthesis Design | 25 | 2022 | 285 | 3.510 |
Why?
| | Heart Septal Defects, Atrial | 8 | 2022 | 51 | 3.480 |
Why?
| | Cardiac Surgical Procedures | 19 | 2021 | 414 | 3.360 |
Why?
| | Treatment Outcome | 75 | 2023 | 9084 | 2.590 |
Why?
| | Pulmonary Artery | 16 | 2022 | 1015 | 2.410 |
Why?
| | Ventricular Outflow Obstruction | 5 | 2023 | 38 | 2.270 |
Why?
| | Pulmonary Veins | 6 | 2023 | 81 | 2.140 |
Why?
| | Hypoplastic Left Heart Syndrome | 6 | 2020 | 109 | 2.020 |
Why?
| | Tetralogy of Fallot | 7 | 2022 | 81 | 1.940 |
Why?
| | Heart Septal Defects, Ventricular | 5 | 2023 | 39 | 1.780 |
Why?
| | Angioplasty, Balloon | 6 | 2020 | 88 | 1.760 |
Why?
| | Hemodynamics | 23 | 2022 | 1012 | 1.660 |
Why?
| | Angiography | 11 | 2021 | 174 | 1.630 |
Why?
| | Pulmonary Valve Stenosis | 4 | 2020 | 16 | 1.590 |
Why?
| | Ductus Arteriosus | 4 | 2017 | 67 | 1.590 |
Why?
| | Cardiology | 5 | 2022 | 259 | 1.520 |
Why?
| | Ductus Arteriosus, Patent | 8 | 2017 | 50 | 1.410 |
Why?
| | Infant | 48 | 2023 | 7959 | 1.350 |
Why?
| | Retrospective Studies | 55 | 2023 | 12542 | 1.330 |
Why?
| | Humans | 139 | 2023 | 114623 | 1.290 |
Why?
| | Echocardiography | 10 | 2023 | 553 | 1.280 |
Why?
| | Stenosis, Pulmonary Vein | 3 | 2023 | 17 | 1.190 |
Why?
| | Heart Atria | 4 | 2023 | 107 | 1.180 |
Why?
| | Heart Valve Diseases | 3 | 2019 | 161 | 1.150 |
Why?
| | Child | 62 | 2023 | 18404 | 1.150 |
Why?
| | Coated Materials, Biocompatible | 2 | 2018 | 54 | 1.150 |
Why?
| | Child, Preschool | 38 | 2023 | 9108 | 1.140 |
Why?
| | Pulmonary Atresia | 3 | 2023 | 20 | 1.110 |
Why?
| | Heart Ventricles | 9 | 2022 | 712 | 1.100 |
Why?
| | Hypertension, Pulmonary | 9 | 2023 | 1727 | 1.100 |
Why?
| | Adolescent | 53 | 2022 | 17831 | 1.070 |
Why?
| | Blood Vessel Prosthesis Implantation | 3 | 2017 | 181 | 1.060 |
Why?
| | Catheterization, Peripheral | 2 | 2023 | 101 | 1.000 |
Why?
| | Endovascular Procedures | 5 | 2020 | 269 | 0.980 |
Why?
| | Male | 77 | 2023 | 55554 | 0.950 |
Why?
| | Prosthesis Failure | 4 | 2018 | 115 | 0.880 |
Why?
| | Extracorporeal Membrane Oxygenation | 3 | 2023 | 241 | 0.880 |
Why?
| | Mitral Valve Stenosis | 2 | 2016 | 21 | 0.870 |
Why?
| | Radiation Exposure | 2 | 2021 | 41 | 0.870 |
Why?
| | Amyloid | 2 | 2021 | 80 | 0.860 |
Why?
| | Pericardial Effusion | 1 | 2023 | 21 | 0.850 |
Why?
| | Blood Pressure | 6 | 2021 | 1538 | 0.840 |
Why?
| | Echocardiography, Transesophageal | 8 | 2019 | 89 | 0.820 |
Why?
| | Aorta, Thoracic | 3 | 2023 | 256 | 0.820 |
Why?
| | Coronary Vessels | 4 | 2023 | 227 | 0.810 |
Why?
| | Intrinsically Disordered Proteins | 1 | 2021 | 15 | 0.780 |
Why?
| | Coronary Vessel Anomalies | 2 | 2013 | 30 | 0.780 |
Why?
| | Amyloidosis | 1 | 2021 | 36 | 0.770 |
Why?
| | Radiography, Interventional | 7 | 2019 | 104 | 0.760 |
Why?
| | Ventricular Dysfunction, Right | 3 | 2022 | 217 | 0.740 |
Why?
| | Virtual Reality | 1 | 2021 | 38 | 0.730 |
Why?
| | Immunoglobulin Light-chain Amyloidosis | 1 | 2020 | 4 | 0.730 |
Why?
| | Bioprosthesis | 2 | 2020 | 36 | 0.720 |
Why?
| | Heart-Assist Devices | 2 | 2023 | 485 | 0.720 |
Why?
| | Female | 67 | 2023 | 59466 | 0.720 |
Why?
| | Immunoglobulin Light Chains | 1 | 2020 | 35 | 0.720 |
Why?
| | Heart Diseases | 4 | 2023 | 331 | 0.720 |
Why?
| | Polytetrafluoroethylene | 2 | 2018 | 25 | 0.710 |
Why?
| | Vascular Stiffness | 6 | 2021 | 407 | 0.710 |
Why?
| | Infant, Newborn | 20 | 2023 | 5043 | 0.710 |
Why?
| | Plasma Cells | 1 | 2020 | 56 | 0.700 |
Why?
| | Thrombosis | 1 | 2023 | 298 | 0.700 |
Why?
| | Ventricular Dysfunction, Left | 6 | 2022 | 358 | 0.690 |
Why?
| | Abnormalities, Multiple | 2 | 2013 | 178 | 0.690 |
Why?
| | Aortic Diseases | 3 | 2022 | 106 | 0.690 |
Why?
| | Fluoroscopy | 7 | 2021 | 139 | 0.680 |
Why?
| | Surgery, Computer-Assisted | 1 | 2020 | 62 | 0.670 |
Why?
| | Echocardiography, Three-Dimensional | 4 | 2023 | 48 | 0.670 |
Why?
| | Aorta | 9 | 2020 | 386 | 0.660 |
Why?
| | Aortography | 3 | 2017 | 50 | 0.660 |
Why?
| | Hypertension | 2 | 2020 | 1056 | 0.650 |
Why?
| | Pediatrics | 4 | 2023 | 979 | 0.640 |
Why?
| | Young Adult | 27 | 2020 | 10455 | 0.640 |
Why?
| | Aneurysm, False | 1 | 2019 | 45 | 0.640 |
Why?
| | Stenosis, Pulmonary Artery | 1 | 2018 | 4 | 0.630 |
Why?
| | Mitral Valve | 2 | 2016 | 86 | 0.630 |
Why?
| | Emergencies | 1 | 2019 | 146 | 0.620 |
Why?
| | Fontan Procedure | 5 | 2020 | 157 | 0.620 |
Why?
| | Chromium Alloys | 1 | 2018 | 5 | 0.610 |
Why?
| | Arterial Switch Operation | 1 | 2018 | 5 | 0.610 |
Why?
| | Catheter Ablation | 2 | 2023 | 288 | 0.600 |
Why?
| | Diagnostic Imaging | 1 | 2020 | 275 | 0.600 |
Why?
| | Transposition of Great Vessels | 1 | 2018 | 29 | 0.590 |
Why?
| | Congresses as Topic | 1 | 2019 | 195 | 0.590 |
Why?
| | Follow-Up Studies | 13 | 2023 | 4411 | 0.580 |
Why?
| | Time Factors | 20 | 2021 | 6112 | 0.580 |
Why?
| | Factor VIIa | 1 | 2017 | 36 | 0.580 |
Why?
| | Percutaneous Coronary Intervention | 2 | 2023 | 444 | 0.580 |
Why?
| | Foreign-Body Migration | 2 | 2017 | 37 | 0.570 |
Why?
| | Hemoptysis | 1 | 2017 | 34 | 0.570 |
Why?
| | Antihypertensive Agents | 1 | 2020 | 429 | 0.560 |
Why?
| | Equipment Design | 9 | 2019 | 508 | 0.540 |
Why?
| | Palliative Care | 4 | 2020 | 642 | 0.540 |
Why?
| | Magnetic Resonance Imaging, Cine | 5 | 2021 | 172 | 0.530 |
Why?
| | Mitral Valve Annuloplasty | 1 | 2016 | 4 | 0.530 |
Why?
| | Arteriovenous Fistula | 1 | 2016 | 29 | 0.520 |
Why?
| | Adult | 34 | 2022 | 30528 | 0.520 |
Why?
| | Pain | 1 | 2021 | 705 | 0.510 |
Why?
| | United Kingdom | 8 | 2018 | 226 | 0.500 |
Why?
| | Videoconferencing | 4 | 2013 | 57 | 0.500 |
Why?
| | Self Expandable Metallic Stents | 1 | 2015 | 14 | 0.490 |
Why?
| | Femoral Vein | 2 | 2011 | 28 | 0.480 |
Why?
| | Hemostatic Techniques | 2 | 2011 | 40 | 0.470 |
Why?
| | Antibodies, Monoclonal | 1 | 2020 | 1262 | 0.460 |
Why?
| | Endocarditis | 1 | 2014 | 32 | 0.450 |
Why?
| | Ventricular Function, Right | 5 | 2022 | 250 | 0.440 |
Why?
| | Aortic Stenosis, Supravalvular | 1 | 2013 | 6 | 0.440 |
Why?
| | Embolism, Air | 1 | 2013 | 11 | 0.430 |
Why?
| | Antibiotic Prophylaxis | 1 | 2014 | 96 | 0.430 |
Why?
| | Williams Syndrome | 1 | 2013 | 15 | 0.430 |
Why?
| | Hemorrhage | 3 | 2011 | 620 | 0.430 |
Why?
| | Loeys-Dietz Syndrome | 1 | 2013 | 6 | 0.430 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2013 | 63 | 0.430 |
Why?
| | Coronary Stenosis | 1 | 2013 | 39 | 0.420 |
Why?
| | Pulmonary Circulation | 5 | 2019 | 407 | 0.420 |
Why?
| | Infant, Low Birth Weight | 1 | 2013 | 125 | 0.420 |
Why?
| | Aneurysm | 1 | 2013 | 29 | 0.420 |
Why?
| | Predictive Value of Tests | 8 | 2022 | 1796 | 0.420 |
Why?
| | Stroke Volume | 6 | 2022 | 504 | 0.410 |
Why?
| | Magnetic Resonance Imaging | 10 | 2020 | 3039 | 0.400 |
Why?
| | Tomography, X-Ray Computed | 5 | 2023 | 2279 | 0.400 |
Why?
| | Hypertension, Renovascular | 1 | 2011 | 12 | 0.400 |
Why?
| | Absorbable Implants | 2 | 2020 | 34 | 0.400 |
Why?
| | Renal Artery | 1 | 2011 | 26 | 0.390 |
Why?
| | Aorta, Abdominal | 1 | 2011 | 39 | 0.390 |
Why?
| | Renal Artery Obstruction | 1 | 2011 | 29 | 0.390 |
Why?
| | Suture Techniques | 1 | 2011 | 115 | 0.370 |
Why?
| | Middle Aged | 24 | 2022 | 26719 | 0.360 |
Why?
| | Weight Gain | 1 | 2013 | 453 | 0.350 |
Why?
| | Platinum | 2 | 2022 | 38 | 0.350 |
Why?
| | Arterial Pressure | 3 | 2021 | 99 | 0.350 |
Why?
| | Surgical Instruments | 1 | 2010 | 47 | 0.350 |
Why?
| | Postoperative Complications | 7 | 2020 | 2128 | 0.340 |
Why?
| | Coronary Angiography | 3 | 2022 | 304 | 0.340 |
Why?
| | Airway Obstruction | 2 | 2023 | 168 | 0.340 |
Why?
| | Hand Deformities, Congenital | 1 | 2009 | 8 | 0.330 |
Why?
| | Coronary Circulation | 3 | 2022 | 133 | 0.330 |
Why?
| | Ontario | 4 | 2013 | 74 | 0.310 |
Why?
| | Catheters | 2 | 2023 | 63 | 0.310 |
Why?
| | Blood Vessel Prosthesis | 1 | 2009 | 112 | 0.310 |
Why?
| | Age Factors | 10 | 2019 | 2894 | 0.310 |
Why?
| | Ventricular Function, Left | 3 | 2020 | 467 | 0.300 |
Why?
| | Imaging, Three-Dimensional | 5 | 2021 | 510 | 0.300 |
Why?
| | Practice Guidelines as Topic | 3 | 2017 | 1394 | 0.300 |
Why?
| | Prospective Studies | 14 | 2023 | 6217 | 0.300 |
Why?
| | Echocardiography, Doppler, Color | 3 | 2019 | 39 | 0.280 |
Why?
| | Off-Label Use | 2 | 2017 | 51 | 0.280 |
Why?
| | Systole | 3 | 2022 | 171 | 0.280 |
Why?
| | Cardiac Catheters | 2 | 2019 | 15 | 0.280 |
Why?
| | Case-Control Studies | 7 | 2023 | 3003 | 0.270 |
Why?
| | Heart Failure | 4 | 2021 | 1945 | 0.270 |
Why?
| | Balloon Valvuloplasty | 2 | 2018 | 3 | 0.270 |
Why?
| | Kidney Transplantation | 1 | 2011 | 541 | 0.260 |
Why?
| | Multimodal Imaging | 3 | 2021 | 88 | 0.250 |
Why?
| | Anti-Bacterial Agents | 1 | 2014 | 1477 | 0.240 |
Why?
| | Risk Factors | 13 | 2023 | 8628 | 0.240 |
Why?
| | Tomography, Optical Coherence | 2 | 2023 | 130 | 0.230 |
Why?
| | Constriction, Pathologic | 2 | 2022 | 208 | 0.230 |
Why?
| | Matrix Metalloproteinase 8 | 1 | 2023 | 9 | 0.220 |
Why?
| | Tracheobronchomalacia | 1 | 2023 | 14 | 0.220 |
Why?
| | Vascular Closure Devices | 1 | 2023 | 6 | 0.220 |
Why?
| | Electrocoagulation | 1 | 2023 | 38 | 0.220 |
Why?
| | North America | 2 | 2022 | 256 | 0.220 |
Why?
| | Societies, Medical | 2 | 2019 | 663 | 0.220 |
Why?
| | Aged | 17 | 2020 | 19061 | 0.220 |
Why?
| | Ventricular Remodeling | 2 | 2022 | 226 | 0.210 |
Why?
| | Pericardium | 1 | 2023 | 50 | 0.210 |
Why?
| | Thrombectomy | 1 | 2023 | 51 | 0.210 |
Why?
| | Cardiopulmonary Bypass | 3 | 2020 | 178 | 0.210 |
Why?
| | Reproducibility of Results | 5 | 2022 | 2762 | 0.210 |
Why?
| | Multicenter Studies as Topic | 1 | 2023 | 248 | 0.200 |
Why?
| | Patient Discharge | 1 | 2008 | 771 | 0.200 |
Why?
| | Glycine Hydroxymethyltransferase | 1 | 2002 | 15 | 0.200 |
Why?
| | Ultrasonography, Interventional | 3 | 2018 | 123 | 0.200 |
Why?
| | Thymidylate Synthase | 1 | 2002 | 11 | 0.200 |
Why?
| | Drainage | 1 | 2023 | 151 | 0.200 |
Why?
| | Double Outlet Right Ventricle | 1 | 2022 | 9 | 0.200 |
Why?
| | Heart Bypass, Right | 1 | 2022 | 15 | 0.200 |
Why?
| | Perfusion Imaging | 2 | 2019 | 51 | 0.200 |
Why?
| | Regional Blood Flow | 2 | 2021 | 424 | 0.200 |
Why?
| | Amyloidogenic Proteins | 1 | 2021 | 9 | 0.200 |
Why?
| | Computed Tomography Angiography | 1 | 2022 | 97 | 0.190 |
Why?
| | Cardiovascular Agents | 1 | 2023 | 126 | 0.190 |
Why?
| | Blood Volume | 2 | 2021 | 59 | 0.190 |
Why?
| | Tissue Inhibitor of Metalloproteinases | 1 | 2021 | 16 | 0.190 |
Why?
| | Postoperative Period | 2 | 2022 | 289 | 0.190 |
Why?
| | Ventricular Function | 1 | 2021 | 57 | 0.190 |
Why?
| | Registries | 4 | 2023 | 1767 | 0.180 |
Why?
| | Pulse Wave Analysis | 2 | 2018 | 207 | 0.180 |
Why?
| | Matrix Metalloproteinases | 1 | 2021 | 89 | 0.180 |
Why?
| | Endothelin-1 | 1 | 2022 | 167 | 0.180 |
Why?
| | London | 2 | 2018 | 43 | 0.180 |
Why?
| | Bronchial Diseases | 1 | 2020 | 38 | 0.180 |
Why?
| | Compassionate Use Trials | 1 | 2020 | 8 | 0.170 |
Why?
| | Feasibility Studies | 2 | 2022 | 739 | 0.170 |
Why?
| | Protein Folding | 1 | 2021 | 239 | 0.170 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2022 | 186 | 0.170 |
Why?
| | Polymorphism, Genetic | 2 | 2004 | 610 | 0.170 |
Why?
| | Anxiety | 2 | 2021 | 840 | 0.170 |
Why?
| | Kynurenine | 1 | 2020 | 81 | 0.170 |
Why?
| | Device Removal | 3 | 2017 | 126 | 0.170 |
Why?
| | Heart Function Tests | 1 | 2019 | 58 | 0.170 |
Why?
| | Stress, Mechanical | 5 | 2019 | 445 | 0.170 |
Why?
| | Tryptophan | 1 | 2020 | 136 | 0.170 |
Why?
| | Practice Patterns, Physicians' | 2 | 2018 | 1177 | 0.170 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2021 | 682 | 0.170 |
Why?
| | Thoracic Injuries | 1 | 2019 | 55 | 0.160 |
Why?
| | Pain Measurement | 1 | 2021 | 444 | 0.160 |
Why?
| | Cyanosis | 2 | 2016 | 15 | 0.160 |
Why?
| | Vascular Access Devices | 1 | 2019 | 24 | 0.160 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2002 | 256 | 0.160 |
Why?
| | Models, Cardiovascular | 1 | 2020 | 178 | 0.160 |
Why?
| | Vascular System Injuries | 1 | 2019 | 66 | 0.160 |
Why?
| | Protein Conformation | 1 | 2021 | 805 | 0.160 |
Why?
| | Blood Proteins | 1 | 2020 | 231 | 0.160 |
Why?
| | Marfan Syndrome | 1 | 2018 | 42 | 0.160 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2023 | 329 | 0.160 |
Why?
| | Compressive Strength | 1 | 2018 | 70 | 0.150 |
Why?
| | Pain Management | 1 | 2021 | 288 | 0.150 |
Why?
| | China | 1 | 2019 | 161 | 0.150 |
Why?
| | Aortic Valve | 2 | 2019 | 398 | 0.150 |
Why?
| | Multiple Myeloma | 2 | 2011 | 93 | 0.150 |
Why?
| | Recovery of Function | 2 | 2019 | 574 | 0.150 |
Why?
| | Atrial Septum | 1 | 2018 | 3 | 0.150 |
Why?
| | Turner Syndrome | 1 | 2018 | 44 | 0.150 |
Why?
| | Radiation Protection | 1 | 2018 | 34 | 0.150 |
Why?
| | Survival Rate | 2 | 2020 | 1644 | 0.150 |
Why?
| | Cardiomyopathies | 1 | 2021 | 298 | 0.150 |
Why?
| | Thermodilution | 1 | 2017 | 12 | 0.150 |
Why?
| | Education, Medical, Graduate | 2 | 2022 | 368 | 0.150 |
Why?
| | Noonan Syndrome | 1 | 2018 | 17 | 0.150 |
Why?
| | Thrombolytic Therapy | 1 | 2018 | 117 | 0.150 |
Why?
| | Severity of Illness Index | 3 | 2019 | 2537 | 0.140 |
Why?
| | Pressure | 3 | 2016 | 214 | 0.140 |
Why?
| | Blood Flow Velocity | 4 | 2020 | 387 | 0.140 |
Why?
| | Dilatation | 1 | 2017 | 60 | 0.140 |
Why?
| | Embolization, Therapeutic | 1 | 2019 | 178 | 0.140 |
Why?
| | Ireland | 4 | 2019 | 24 | 0.140 |
Why?
| | Cardiologists | 1 | 2017 | 40 | 0.140 |
Why?
| | Vascular Remodeling | 1 | 2018 | 153 | 0.140 |
Why?
| | Swine | 1 | 2019 | 700 | 0.140 |
Why?
| | Hematopoietic Stem Cell Transplantation | 2 | 2012 | 520 | 0.140 |
Why?
| | Wounds, Nonpenetrating | 1 | 2019 | 256 | 0.140 |
Why?
| | Radiography, Thoracic | 1 | 2017 | 150 | 0.140 |
Why?
| | Femoral Artery | 2 | 2023 | 167 | 0.130 |
Why?
| | Mitral Valve Insufficiency | 1 | 2016 | 63 | 0.130 |
Why?
| | Pulmonary Veno-Occlusive Disease | 1 | 2016 | 11 | 0.130 |
Why?
| | Early Medical Intervention | 1 | 2016 | 52 | 0.130 |
Why?
| | Magnetic Resonance Angiography | 2 | 2018 | 219 | 0.130 |
Why?
| | Observer Variation | 1 | 2017 | 295 | 0.130 |
Why?
| | Nitric Oxide | 1 | 2021 | 823 | 0.130 |
Why?
| | United States | 5 | 2020 | 12176 | 0.130 |
Why?
| | Superior Vena Cava Syndrome | 1 | 2015 | 3 | 0.130 |
Why?
| | Length of Stay | 1 | 2020 | 962 | 0.130 |
Why?
| | Heart Transplantation | 1 | 2021 | 665 | 0.120 |
Why?
| | Aortic Valve Stenosis | 1 | 2019 | 272 | 0.120 |
Why?
| | Body Weight | 2 | 2017 | 868 | 0.120 |
Why?
| | Recurrence | 3 | 2013 | 935 | 0.120 |
Why?
| | Kaplan-Meier Estimate | 1 | 2017 | 811 | 0.120 |
Why?
| | Punctures | 2 | 2011 | 36 | 0.120 |
Why?
| | Oxygen Consumption | 1 | 2017 | 588 | 0.120 |
Why?
| | Models, Theoretical | 1 | 2018 | 515 | 0.120 |
Why?
| | Tricuspid Atresia | 1 | 2014 | 6 | 0.120 |
Why?
| | Truncus Arteriosus, Persistent | 1 | 2014 | 6 | 0.120 |
Why?
| | Transplantation, Autologous | 2 | 2011 | 176 | 0.120 |
Why?
| | Recombinant Proteins | 1 | 2017 | 1230 | 0.120 |
Why?
| | Anticoagulants | 1 | 2018 | 550 | 0.120 |
Why?
| | Radiography | 3 | 2014 | 812 | 0.110 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2016 | 152 | 0.110 |
Why?
| | Genetic Predisposition to Disease | 1 | 2002 | 2084 | 0.110 |
Why?
| | Computer Communication Networks | 1 | 2013 | 32 | 0.110 |
Why?
| | Vascular Diseases | 1 | 2016 | 230 | 0.110 |
Why?
| | Diseases in Twins | 1 | 2014 | 174 | 0.110 |
Why?
| | Incidence | 3 | 2018 | 2311 | 0.110 |
Why?
| | Cerebral Hemorrhage | 1 | 2013 | 96 | 0.110 |
Why?
| | Remote Consultation | 1 | 2013 | 42 | 0.110 |
Why?
| | Canada | 1 | 2014 | 322 | 0.110 |
Why?
| | Aged, 80 and over | 3 | 2020 | 6344 | 0.110 |
Why?
| | Foramen Ovale, Patent | 1 | 2013 | 45 | 0.100 |
Why?
| | Home Care Services | 2 | 2013 | 222 | 0.100 |
Why?
| | Combined Modality Therapy | 2 | 2015 | 1121 | 0.100 |
Why?
| | Ultrasonography | 3 | 2010 | 633 | 0.100 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 1 | 2013 | 61 | 0.100 |
Why?
| | Fatal Outcome | 1 | 2013 | 284 | 0.100 |
Why?
| | Health Surveys | 1 | 2014 | 443 | 0.100 |
Why?
| | Matrix Metalloproteinase 7 | 2 | 2023 | 25 | 0.100 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2012 | 190 | 0.100 |
Why?
| | Cystitis | 1 | 2011 | 20 | 0.090 |
Why?
| | Starch | 1 | 2011 | 20 | 0.090 |
Why?
| | Bandages | 1 | 2011 | 31 | 0.090 |
Why?
| | Hematologic Neoplasms | 1 | 2012 | 137 | 0.090 |
Why?
| | Syndrome | 1 | 2011 | 333 | 0.090 |
Why?
| | Vital Signs | 2 | 2021 | 37 | 0.090 |
Why?
| | Hemostatics | 1 | 2011 | 47 | 0.090 |
Why?
| | Graft vs Host Disease | 1 | 2012 | 212 | 0.090 |
Why?
| | Tertiary Care Centers | 3 | 2017 | 126 | 0.090 |
Why?
| | Electrocardiography | 2 | 2013 | 560 | 0.090 |
Why?
| | Graft Occlusion, Vascular | 1 | 2010 | 35 | 0.090 |
Why?
| | Exercise Test | 1 | 2013 | 544 | 0.090 |
Why?
| | Stem Cell Transplantation | 1 | 2011 | 149 | 0.090 |
Why?
| | Teleradiology | 1 | 2009 | 4 | 0.090 |
Why?
| | Disease Models, Animal | 1 | 2019 | 3531 | 0.090 |
Why?
| | Myocardial Perfusion Imaging | 2 | 2020 | 34 | 0.080 |
Why?
| | Telemedicine | 2 | 2008 | 662 | 0.080 |
Why?
| | Balloon Occlusion | 1 | 2009 | 26 | 0.080 |
Why?
| | Patient-Specific Modeling | 2 | 2020 | 36 | 0.080 |
Why?
| | Critical Care | 1 | 2013 | 476 | 0.080 |
Why?
| | Aortic Aneurysm | 1 | 2009 | 55 | 0.080 |
Why?
| | Electrodes, Implanted | 1 | 2009 | 91 | 0.080 |
Why?
| | Catheterization | 1 | 2009 | 159 | 0.080 |
Why?
| | Health Care Costs | 2 | 2009 | 381 | 0.080 |
Why?
| | Myocardial Contraction | 2 | 2020 | 313 | 0.080 |
Why?
| | Cohort Studies | 2 | 2015 | 4894 | 0.080 |
Why?
| | Pacemaker, Artificial | 1 | 2009 | 106 | 0.080 |
Why?
| | Peripheral Blood Stem Cell Transplantation | 1 | 2007 | 19 | 0.070 |
Why?
| | Histocompatibility | 1 | 2007 | 26 | 0.070 |
Why?
| | Patient Satisfaction | 2 | 2008 | 578 | 0.070 |
Why?
| | Telephone | 1 | 2008 | 152 | 0.070 |
Why?
| | Patient Readmission | 1 | 2012 | 609 | 0.070 |
Why?
| | In Vitro Techniques | 1 | 2009 | 1016 | 0.070 |
Why?
| | Elastic Modulus | 2 | 2019 | 116 | 0.070 |
Why?
| | Vascular Surgical Procedures | 1 | 2009 | 259 | 0.070 |
Why?
| | Bone Marrow Transplantation | 1 | 2007 | 239 | 0.070 |
Why?
| | Proteomics | 2 | 2023 | 836 | 0.070 |
Why?
| | Neonatal Screening | 1 | 2008 | 152 | 0.070 |
Why?
| | Materials Testing | 2 | 2019 | 337 | 0.070 |
Why?
| | Echocardiography, Doppler | 2 | 2018 | 91 | 0.070 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2008 | 222 | 0.060 |
Why?
| | England | 3 | 2013 | 65 | 0.060 |
Why?
| | Continuity of Patient Care | 1 | 2008 | 253 | 0.060 |
Why?
| | Tissue Donors | 1 | 2007 | 316 | 0.060 |
Why?
| | Stroke | 1 | 2013 | 1021 | 0.060 |
Why?
| | Hypoxia | 2 | 2022 | 957 | 0.060 |
Why?
| | Reoperation | 2 | 2018 | 514 | 0.060 |
Why?
| | Biomarkers | 3 | 2023 | 3408 | 0.060 |
Why?
| | Social Support | 1 | 2008 | 528 | 0.060 |
Why?
| | Equipment Failure | 2 | 2019 | 106 | 0.060 |
Why?
| | Risk Assessment | 3 | 2023 | 2967 | 0.060 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 2004 | 71 | 0.060 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2023 | 25 | 0.060 |
Why?
| | DNA Helicases | 1 | 2004 | 133 | 0.050 |
Why?
| | Equipment Failure Analysis | 2 | 2016 | 132 | 0.050 |
Why?
| | Extracellular Matrix Proteins | 1 | 2023 | 127 | 0.050 |
Why?
| | 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2002 | 16 | 0.050 |
Why?
| | Sirolimus | 1 | 2023 | 181 | 0.050 |
Why?
| | Bronchoscopy | 1 | 2023 | 245 | 0.050 |
Why?
| | Endothelium-Dependent Relaxing Factors | 1 | 2021 | 18 | 0.050 |
Why?
| | Replantation | 1 | 2021 | 33 | 0.050 |
Why?
| | Folic Acid | 1 | 2002 | 161 | 0.050 |
Why?
| | Databases, Factual | 2 | 2016 | 1124 | 0.050 |
Why?
| | Polydioxanone | 1 | 2020 | 3 | 0.040 |
Why?
| | Parents | 1 | 2008 | 1186 | 0.040 |
Why?
| | Models, Chemical | 1 | 2002 | 248 | 0.040 |
Why?
| | Photoplethysmography | 1 | 2020 | 15 | 0.040 |
Why?
| | Proof of Concept Study | 1 | 2020 | 45 | 0.040 |
Why?
| | Preoperative Period | 1 | 2020 | 103 | 0.040 |
Why?
| | Hypertrophy | 1 | 2020 | 109 | 0.040 |
Why?
| | Extracellular Matrix | 1 | 2023 | 436 | 0.040 |
Why?
| | Electrophysiological Phenomena | 1 | 2019 | 48 | 0.040 |
Why?
| | Airway Management | 1 | 2020 | 60 | 0.040 |
Why?
| | Genetic Variation | 1 | 2004 | 870 | 0.040 |
Why?
| | Principal Component Analysis | 1 | 2020 | 175 | 0.040 |
Why?
| | Diastole | 1 | 2019 | 130 | 0.040 |
Why?
| | Odds Ratio | 1 | 2002 | 953 | 0.040 |
Why?
| | Italy | 1 | 2019 | 92 | 0.040 |
Why?
| | Infant, Premature | 1 | 2023 | 476 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2021 | 641 | 0.040 |
Why?
| | Collateral Circulation | 1 | 2019 | 19 | 0.040 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2020 | 141 | 0.040 |
Why?
| | Transplantation, Homologous | 2 | 2012 | 377 | 0.040 |
Why?
| | Mechanical Phenomena | 1 | 2019 | 80 | 0.040 |
Why?
| | Autografts | 1 | 2019 | 40 | 0.040 |
Why?
| | Altitude | 1 | 2023 | 432 | 0.040 |
Why?
| | Anatomic Landmarks | 1 | 2019 | 23 | 0.040 |
Why?
| | Bronchi | 1 | 2020 | 231 | 0.040 |
Why?
| | Chromatography, Liquid | 1 | 2020 | 347 | 0.040 |
Why?
| | Alcohol Drinking | 1 | 2004 | 651 | 0.040 |
Why?
| | Dilatation, Pathologic | 1 | 2018 | 55 | 0.040 |
Why?
| | Serotonin | 1 | 2020 | 292 | 0.040 |
Why?
| | Multivariate Analysis | 1 | 2002 | 1430 | 0.040 |
Why?
| | Heart Rate | 2 | 2021 | 709 | 0.040 |
Why?
| | Anastomosis, Surgical | 1 | 2018 | 136 | 0.040 |
Why?
| | Animals | 2 | 2019 | 31694 | 0.040 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2004 | 534 | 0.040 |
Why?
| | Vascular Resistance | 2 | 2019 | 337 | 0.040 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2019 | 98 | 0.040 |
Why?
| | Poland | 1 | 2018 | 28 | 0.040 |
Why?
| | Shear Strength | 1 | 2018 | 65 | 0.040 |
Why?
| | Prognosis | 2 | 2018 | 3328 | 0.040 |
Why?
| | Cardiac Output | 2 | 2017 | 143 | 0.040 |
Why?
| | Telemetry | 2 | 2008 | 36 | 0.040 |
Why?
| | Body Size | 1 | 2018 | 91 | 0.040 |
Why?
| | DNA-Binding Proteins | 1 | 2004 | 1314 | 0.040 |
Why?
| | Smoking | 1 | 2004 | 1380 | 0.040 |
Why?
| | Internet | 2 | 2013 | 596 | 0.040 |
Why?
| | Stereotaxic Techniques | 1 | 2017 | 29 | 0.040 |
Why?
| | Mass Spectrometry | 1 | 2020 | 633 | 0.040 |
Why?
| | Genotype | 1 | 2002 | 1760 | 0.040 |
Why?
| | Transcription Factors | 1 | 2004 | 1528 | 0.030 |
Why?
| | Biomechanical Phenomena | 1 | 2018 | 668 | 0.030 |
Why?
| | Metabolomics | 1 | 2020 | 521 | 0.030 |
Why?
| | Contraindications | 1 | 2015 | 85 | 0.030 |
Why?
| | Norwood Procedures | 1 | 2015 | 22 | 0.030 |
Why?
| | Health Care Surveys | 1 | 2017 | 539 | 0.030 |
Why?
| | Hospitals, Pediatric | 1 | 2018 | 480 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 268 | 0.030 |
Why?
| | Oxygen | 1 | 2018 | 854 | 0.030 |
Why?
| | Remission Induction | 1 | 2014 | 233 | 0.030 |
Why?
| | Ligation | 1 | 2013 | 75 | 0.030 |
Why?
| | Alloys | 1 | 2013 | 30 | 0.030 |
Why?
| | Software | 1 | 2017 | 529 | 0.030 |
Why?
| | Algorithms | 1 | 2020 | 1466 | 0.030 |
Why?
| | Guideline Adherence | 1 | 2017 | 490 | 0.030 |
Why?
| | Patient Care Team | 1 | 2017 | 517 | 0.030 |
Why?
| | Disease Progression | 1 | 2018 | 2380 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2015 | 1691 | 0.020 |
Why?
| | Hematoma | 1 | 2011 | 49 | 0.020 |
Why?
| | Cost of Illness | 1 | 2012 | 254 | 0.020 |
Why?
| | Lung | 1 | 2023 | 3558 | 0.020 |
Why?
| | Clinical Competence | 1 | 2017 | 893 | 0.020 |
Why?
| | Thoracotomy | 1 | 2010 | 75 | 0.020 |
Why?
| | Hospitals, District | 1 | 2009 | 4 | 0.020 |
Why?
| | Northern Ireland | 1 | 2009 | 7 | 0.020 |
Why?
| | Hospitals, General | 1 | 2009 | 19 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2011 | 493 | 0.020 |
Why?
| | Colorado | 1 | 2019 | 4099 | 0.020 |
Why?
| | Cardiology Service, Hospital | 1 | 2009 | 28 | 0.020 |
Why?
| | Unnecessary Procedures | 1 | 2009 | 44 | 0.020 |
Why?
| | Data Collection | 1 | 2011 | 620 | 0.020 |
Why?
| | Hemoglobins | 1 | 2010 | 315 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 4405 | 0.020 |
Why?
| | Patient Transfer | 1 | 2009 | 143 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2018 | 4620 | 0.020 |
Why?
| | Acute Disease | 1 | 2009 | 910 | 0.020 |
Why?
| | Siblings | 1 | 2007 | 221 | 0.020 |
Why?
| | Hospital Mortality | 1 | 2010 | 776 | 0.020 |
Why?
| | Patient Selection | 1 | 2009 | 641 | 0.020 |
Why?
| | Pilot Projects | 1 | 2009 | 1372 | 0.020 |
Why?
| | Xeroderma Pigmentosum Group D Protein | 1 | 2004 | 4 | 0.020 |
Why?
| | Aging | 1 | 2014 | 1618 | 0.010 |
Why?
| | Codon | 1 | 2004 | 86 | 0.010 |
Why?
| | Medical History Taking | 1 | 2004 | 114 | 0.010 |
Why?
| | DNA Repair | 1 | 2004 | 184 | 0.010 |
Why?
| | Pregnancy | 1 | 2014 | 5517 | 0.010 |
Why?
| | Phenytoin | 1 | 1970 | 14 | 0.010 |
Why?
| | Digoxin | 1 | 1970 | 26 | 0.010 |
Why?
| | Ventricular Fibrillation | 1 | 1970 | 51 | 0.000 |
Why?
| | Dogs | 1 | 1970 | 334 | 0.000 |
Why?
| | Heart Arrest | 1 | 1970 | 292 | 0.000 |
Why?
|
|
Morgan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|